- Single-blind multicenter randomized trial at 10 French tertiary centers enrolled 172 adults undergoing elective cardiac surgery with cardiopulmonary bypass; stopped early by the data and safety monitoring board.
- Individualized MAP targeting (within ±10% of preoperative baseline, intraoperatively and for 24 hours postoperatively) was compared with a standard target MAP of at least 65 mm Hg.
- The primary composite occurred in 32% versus 29% (relative risk 1.1; 95% CI 0.7 to 1.8; P=0.76), while hemorrhagic complications were 18% versus 3% (P=0.003).
- The authors could not determine whether individualized MAP reduced major postoperative complications and flagged the increased bleeding as a safety signal for future studies.
Cardiac
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Randomized, double-blind, placebo-controlled single-center trial of 70 patients undergoing on-pump CABG.
- Patients received intranasal dexmedetomidine 1 μg/kg or saline on the night before surgery and again 30 minutes before induction.
- At 24 hours, estimated marginal mean hs-cTnT was 170.29 vs 357.29 ng/L (P < 0.001) favoring dexmedetomidine; CK-MB was also lower.
- Sleep quality scores were higher and postoperative delirium was lower (14.3% vs 37.1%; P = 0.029), but the authors call the findings preliminary.
AI summary not available. Read the source abstract on PubMed.
- Single-center, single-blind randomized trial in a French cardiac surgery center enrolling 128 adults undergoing elective cardiac surgery with cardiopulmonary bypass, 126 analyzed.
- Patients received bilateral ultrasound-guided deep parasternal intercostal plane blocks with 40 mL ropivacaine versus standard care.
- The primary outcome, Quality of Recovery-15 at 24 hours, did not differ significantly (mean difference 3.9 points, 95% CI -3.3 to 11.2; p = 0.230), though resting pain was lower with the block at hours 2, 6, and 48.
- The authors conclude the block did not improve 24-hour recovery in mixed patients, and a non-prespecified subgroup analysis in internal mammary artery harvesting patients (n = 71) suggested possible benefit needing confirmation.
- Single-center, prospective cluster-randomized trial by month in cardiac surgery patients receiving intraoperative cryoprecipitate, stopped early at 170 of 502 planned patients.
- Pathogen-reduced cryoprecipitated fibrinogen complex (PR CRYO, storable at room temperature post-thaw) was compared with conventional cryoprecipitate (Cryo).
- Total blood components transfused were identical (6 units, IQR 3-12, p > 0.9), while PR CRYO was issued 19 min faster (12 vs. 31 min, p < 0.001) and transfusion began 16 min sooner (46 vs. 62 min, p = 0.008).
- No reduction in 30-day transfusions was shown, adverse events and 3-day transfusions were similar, and equivalence could not be formally concluded.
- This prospective randomized trial enrolled 271 adults undergoing elective sternotomy at a single center, randomized 1:1:1 to standard therapy, ESP block, or SPIP block.
- Both fascial plane blocks were added to a multimodal analgesic regimen and compared with the control group receiving standard therapy alone.
- Opioid use did not differ significantly on postoperative days 0 to 2; a day 3 difference favored ESP (p = 0.047). Maximum pain scores were lower in both block groups on days 0 to 3 (POD 1 p < 0.001, POD 2 p < 0.001, POD 3 p = 0.002).
- The authors conclude that patients undergoing sternotomy may benefit from adding either ESP or SPIP blocks to a multimodal postoperative regimen.
- Single-center, blinded-assessor randomized trial of 76 adults undergoing elective open cardiac surgery via median sternotomy.
- Bilateral serratus posterior superior intercostal plane block (SPSIPB) was compared with bilateral parasternal plane block plus chest drain-site infiltration (PSIPB), both performed preoperatively under ultrasound guidance.
- Cumulative 24-hour opioid consumption was lower with SPSIPB (mean difference 20.1 MME, 95% CI 11.7-28.5; p < 0.001) in the 33 and 31 patients analyzed.
- The authors report higher 24-hour QoR-15 scores with SPSIPB (median difference 10 points, 95% CI 6-15), above the 6-point minimal clinically important difference, with no difference in adverse events.
- Randomized controlled trial of 172 patients after elective CABG or valve surgery, allocated to five noninvasive ventilation or high-flow interfaces versus physiotherapy alone in one tertiary ICU.
- Compared a conventional oronasal mask, conventional full-face mask, Wolf Mask, ELMO helmet CPAP, and high-flow nasal cannula, each given three 60-minute daily sessions alongside standard physiotherapy.
- The Wolf Mask had the highest comfort score (9.41 ± 0.68 on a 0-10 VAS) and lowest inspiratory pressure support (5.62 ± 2.08 cmH₂O); interface comfort predicted mobilization progression (p = 0.004).
- The authors conclude full-face interfaces are associated with greater comfort, and they describe the pulmonary and oxygenation findings as exploratory and hypothesis-generating, requiring multicenter confirmation.
- A preplanned secondary analysis of a single-center, double-blind, 3-arm randomized trial in 34 adults undergoing elective CABG with cardiopulmonary bypass.
- Patients received albumin-based, gelofusine-based, or retrograde autologous priming (reference), with Stewart acid-base variables measured at five perioperative time points.
- Bypass initiation caused metabolic acidosis (-0.1 pH, -4.3 mmol/L standard base excess, -6.6 mEq/L effective strong ion difference), and these measures did not differ among priming strategies.
- Each extra liter of crystalloid independently lowered pH (-0.011; p = 0.035) and effective strong ion difference (-1.03 mEq/L; p = 0.025), which the authors attribute to crystalloid load rather than colloid choice.
- Prospective, open-label randomized trial of 105 adults aged 60 or older with moderate renal insufficiency undergoing elective OPCAB, split equally into three groups.
- Dexmedetomidine 0.4 μg/kg/h without a loading dose and dopamine 3 μg/kg/min were each compared with a normal saline control, infused from induction through 24 postoperative hours.
- Dexmedetomidine raised urine output (p < 0.01) and eGFR (p < 0.0001) versus dopamine and control at days 1 and 2; creatinine and BUN differences were not clinically significant.
- No group developed AKI by AKIN criteria, adverse events were similar across groups (p = 0.31), and the authors conclude neither drug prevented AKI beyond control.
- International, double-blind, placebo-controlled randomised trial of 955 adults with anaemia awaiting elective cardiac surgery, across 33 hospitals in 10 countries.
- Participants were randomised to 1000 mg intravenous iron or placebo 1 to 26 weeks before surgery.
- Days alive and at home at 90 days were 81.1 with iron versus 80.0 with placebo (adjusted median difference 1.0 day, 95.4% CI 0.0 to 2.1, P=0.041).
- Transfusion during hospital stay was 61.1% with iron versus 68.2% with placebo (RR 0.90, 95% CI 0.82 to 0.99, P=0.027); complications and stay did not differ.